? This proposal is designed to allow the primary investigator, Dr. McConnell, to develop the intellectual and technical skills to become an independently-funded research scientist in the field of gastroenterology disease research. Dr. McConnell's research interests focus on Kruppel-like factor 5 (KLF5), a pro-proliferative transcription factor that is highly expressed in epithelial cells of the mammalian gut. Previously, the laboratory has shown that KLF5 is an important factor for promoting proliferation and mediating inflammatory responses in intestinal epithelial cells. Preliminary evidence for this proposal reveals that expression of KLF5 is induced in response to bacterial infection in both cultured intestinal epithelial cells and in mouse colon. From these findings, it is hypothesized that KLF5 promotes tissue homeostasis in the intestinal epithelium by enhancing proliferative and inflammatory responses to bacterial infection or other stress stimuli. Therefore, the specific aims of this study are: (1) To examine the impact of reduced KLF5 expression on colonic epithelial hyperplasia, inflammation and extent of infection following exposure to enteric pathogenic bacteria, using a Klf5-heterozygous mouse model (2) To identify the molecular mechanisms by which KLF5 promotes proliferation and/or inflammation in response to enteric bacterial infection, and (3) To develop an intestinal-specific Klf5 knockout mouse as a definitive model for examining the role of KLF5 in response to various intestinal insults. To address Specific Aim (1), Klf5-heterozygous mice will be infected with the enteric pathogenic bacteria, Citrobacter rodentium. Extent of hyperplasia and inflammation will be assessed by immunohistochemical and biochemical methods over the time course of infection. To address Specific Aim II, the ability of Klf5 to enhance canonical pathways of proliferation and inflammation will be examined. In addition, microarray studies will be conducted to identify downstream targets of Klf5. Finally, for Specific Aim III, a transgenic mouse for intestinal-specific knockout of Klf5 will be generated in order to test the impact of Klf5 expression on responses to various intestinal insults. The proposed research project will contribute to understanding proliferative and inflammatory responses that occur in the intestines following exposure to bacterial pathogens. This knowledge will provide insights in developing treatments for inflammatory bowel disease. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
1K01DK076742-01A1
Application #
7320375
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
2007-08-01
Project End
2012-06-30
Budget Start
2007-08-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$116,960
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Nagalingam, Arumugam; Kuppusamy, Panjamurthy; Singh, Shivendra V et al. (2014) Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer. Cancer Res 74:2617-29
Avtanski, Dimiter B; Nagalingam, Arumugam; Bonner, Michael Y et al. (2014) Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Mol Oncol 8:565-80
Saxena, Neeraj K; Sharma, Dipali (2013) Multifaceted leptin network: the molecular connection between obesity and breast cancer. J Mammary Gland Biol Neoplasia 18:309-20
Taliaferro-Smith, LaTonia; Nagalingam, Arumugam; Knight, Brandi Brandon et al. (2013) Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis. Neoplasia 15:23-38
Yan, Dan; Avtanski, Dimiter; Saxena, Neeraj K et al. (2012) Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires ?-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem 287:8598-612
Nagalingam, Arumugam; Tighiouart, Mourad; Ryden, Lisa et al. (2012) Med1 plays a critical role in the development of tamoxifen resistance. Carcinogenesis 33:918-30
Nagalingam, Arumugam; Arbiser, Jack L; Bonner, Michael Y et al. (2012) Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res 14:R35
Knight, Brandi B; Oprea-Ilies, Gabriela M; Nagalingam, Arumugam et al. (2011) Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. Endocr Relat Cancer 18:413-28
McConnell, Beth B; Kim, Samuel S; Yu, Ke et al. (2011) Krüppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology 141:1302-13, 1313.e1-6
McConnell, Beth B; Kim, Samuel S; Bialkowska, Agnieszka B et al. (2011) Kruppel-like factor 5 protects against dextran sulfate sodium-induced colonic injury in mice by promoting epithelial repair. Gastroenterology 140:540-549.e2

Showing the most recent 10 out of 23 publications